Atalanta Therapeutics has launched out of UMass with $110m in combined series A and partnership funding to develop therapies for neurodegenerative diseases.

Three years after launching to commercialise stem cell research from Harvard University, Sana has filed for an initial public offering.

Luba Greenwood has been brought on to run Binney Street Capital on behalf of cancer research and care provider Dana-Farber Cancer Institute.

The Intel-backed healthcare analytics technology provider has closed a new round with investments from AllegisNL Capital and Blue Venture Fund.

Guardian Strategic Ventures and Unum Business Ventures helped the healthcare benefits management service close its series A round at $11m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Zühlke Ventures has backed the medical device developer's series A round, which was led by Arboretum Ventures.

Kaiser Foundation Hospitals and Medpace took part in a round that will support phase 3 trials for the startup's lead cardiometabolic disease drug candidate.

The behavioural health assistance platform will get a public listing through the deal, which follows $110m from investors including SoftBank.

Illumina Ventures and AV8 Ventures returned for a series A round that will push the startup's liquid biopsy technology towards the clinical trial stage.